title: A multicentre cohort experience with double-boosted protease inhibitors.
authors.forename: Justin
authors.initials: J
authors.lastname: Stebbing
authors.forename: Andrew
authors.initials: A
authors.lastname: Scourfield
authors.forename: Gavin
authors.initials: G
authors.lastname: Koh
authors.forename: Clare
authors.initials: C
authors.lastname: Taylor
authors.forename: Stephen
authors.initials: S
authors.lastname: Taylor
authors.forename: Edmund
authors.initials: E
authors.lastname: Wilkins
authors.forename: Brian
authors.initials: B
authors.lastname: Gazzard
authors.forename: Mark
authors.initials: M
authors.lastname: Nelson
authors.forename: Rachael
authors.initials: R
authors.lastname: Jones
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D006113:United Kingdom
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors